This Charles River Analyst Turns Bullish; Here Are Top 4 Upgrades For Wednesday

Credicorp Ltd.
BLOOM ENERGY CORP
Constellation Energy Corporation
Hemab Therapeutics Holdings
Charles River Laboratories International, Inc.

Credicorp Ltd.

BAP

0.00

BLOOM ENERGY CORP

BE

0.00

Constellation Energy Corporation

CEG

0.00

Hemab Therapeutics Holdings

COAG

0.00

Charles River Laboratories International, Inc.

CRL

0.00

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • BTIG analyst Douglas Harter upgraded TPG Mortgage Investment Trust Inc (NYSE:MITT) from Neutral to Buy and announced a $9 price target. TPG Mortgage Investment shares closed at $7.94 on Tuesday. See how other analysts view this stock.
  • BTIG analyst Douglas Harter upgraded Mfa Financial Inc (NYSE:MFA) from Neutral to Buy and announced a $10.5 price target. MFA Finl shares closed at $9.38 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst Jorge Kuri upgraded Credicorp Ltd (NYSE:BAP) from Equal-Weight to Overweight and raised the price target from $375 to $480. Credicorp shares closed at $364.28 on Tuesday. See how other analysts view this stock.
  • Morgan Stanley analyst Ricky Goldwasser upgraded Charles River Laboratories International, Inc. (NYSE:CRL) from Equal-Weight to Overweight and raised the price target from $185 to $220. Charles River shares closed at $184.79 on Tuesday. See how other analysts view this stock.

Considering buying MFA stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.